Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.

Detalles Bibliográficos
Autores principales: Amirabadi, Amir, Alami, Amirhosein, Ahanchian, Hamid, Ariaee, Nazila, Moazzen, Nasrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142310/
https://www.ncbi.nlm.nih.gov/pubmed/34084482
http://dx.doi.org/10.1002/ccr3.4021
_version_ 1783696524945915904
author Amirabadi, Amir
Alami, Amirhosein
Ahanchian, Hamid
Ariaee, Nazila
Moazzen, Nasrin
author_facet Amirabadi, Amir
Alami, Amirhosein
Ahanchian, Hamid
Ariaee, Nazila
Moazzen, Nasrin
author_sort Amirabadi, Amir
collection PubMed
description Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.
format Online
Article
Text
id pubmed-8142310
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81423102021-06-02 Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma Amirabadi, Amir Alami, Amirhosein Ahanchian, Hamid Ariaee, Nazila Moazzen, Nasrin Clin Case Rep Case Reports Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it. John Wiley and Sons Inc. 2021-03-24 /pmc/articles/PMC8142310/ /pubmed/34084482 http://dx.doi.org/10.1002/ccr3.4021 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Amirabadi, Amir
Alami, Amirhosein
Ahanchian, Hamid
Ariaee, Nazila
Moazzen, Nasrin
Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
title Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
title_full Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
title_fullStr Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
title_full_unstemmed Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
title_short Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
title_sort epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142310/
https://www.ncbi.nlm.nih.gov/pubmed/34084482
http://dx.doi.org/10.1002/ccr3.4021
work_keys_str_mv AT amirabadiamir epidermalgrowthfactorreceptorinhibitorinadvancedbasalcellcarcinoma
AT alamiamirhosein epidermalgrowthfactorreceptorinhibitorinadvancedbasalcellcarcinoma
AT ahanchianhamid epidermalgrowthfactorreceptorinhibitorinadvancedbasalcellcarcinoma
AT ariaeenazila epidermalgrowthfactorreceptorinhibitorinadvancedbasalcellcarcinoma
AT moazzennasrin epidermalgrowthfactorreceptorinhibitorinadvancedbasalcellcarcinoma

Ejemplares similares